The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication  by Zannetti, Claudia et al.
06) 79–86
www.elsevier.com/locate/yviroVirology 349 (20The expression of p16INK4a tumor suppressor is upregulated by human
cytomegalovirus infection and required for optimal viral replication
Claudia Zannetti a, Michele Mondini a,b, Marco De Andrea a, Patrizia Caposio a, Eiji Hara c,
Gordon Peters d, Giorgio Gribaudo a, Marisa Gariglio b, Santo Landolfo a,⁎
a Department of Public Health and Microbiology, University of Torino, Via Santena, 9-10126 Torino, Italy
b Department of Medical Sciences, University of Eastern Piedmont, Novara, Italy
c Division of Protein Information, Institute for Genome Research, University of Tokushima, Tokushima, Japan
d Cancer Research UK, London Research Institute, London, UK
Received 10 October 2005; returned to author for revision 28 November 2005; accepted 25 January 2006
Available online 28 February 2006Abstract
The human cytomegalovirus (HCMV) induces a replicative senescence program after arresting host cell cycle progression so as to create a
favorable environment for its replication. Here, we report that HCMV infection stimulates the expression of p16INK4a, a direct effector of the
senescence phenotype. The increase in p16INK4a gene expression was due to an increase in gene transcription, since the expression of a reporter
gene driven by the p16INK4a-encoding CDKN2A gene promoter was strongly induced by HCMV infection. The results of deletion and mutational
analysis of the CDKN2A promoter further suggest the involvement of Ets transcription factors in HCMV-mediated stimulation of p16INK4a gene
expression. The significance of p16INK4a upregulation during the HCMV replicative cycle is underscored by the finding that virus replication was
severely impaired in fibroblasts homozygous for an intragenic deletion in CDKN2A locus and devoid of functional p16INK4a. Moreover, a
retrovirus-mediated p16INK4a small interfering RNA (p16-siRNA) effectively reduced viral replication, thus providing direct evidence that
p16INK4a upregulation plays a positive role for HCMV replication.
© 2006 Elsevier Inc. All rights reserved.Keywords: Human cytomegalovirus; Replication; p16INK4a; SenescenceIntroduction
HCMV induces a rather unique cell cycle arrest, preceded by
a virally mediated mitogenic response of infected cells.
Fibroblasts experimentally infected in vitro by HCMV are
halted in both the G1/S and G2/M compartments, depending on
the cell cycle phase where infection occurs (Mocarski and
Courcelle, 2001; Pass, 2001; Kalejta and Shenk, 2002; Land-
olfo et al., 2003), and many S-phase-promoting activities are
induced at the same time (Gribaudo et al., 2002; Lembo et al.,
1998). HCMV-induced dysregulation of host cell cycle stems
from the activities of both viral proteins (IE1, IE2, UL69, and
UL82) and cellular regulators whose expression is modulated
by viral infection such as tumor suppressors, cyclins, and⁎ Corresponding author. Fax: +39 011 6705647.
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doi:10.1016/j.virol.2006.01.042cyclins-dependent kinase inhibitors (cdki) (Castillo and Kowa-
lik, 2002; Fortunato and Spector, 1999). p16INK4a (p16) is the
prototype of a family of cdki which interacts with Cdk4 and
Cdk6. It prevents the inactivation of pRb and causes a G1-phase
block accompanied by an irreversible growth arrest termed
replicative senescence (reviewed in Drayton and Peters, 2002).
The evidence linking p16 to senescence is compelling: (i) p16
accumulates when human diploid fibroblasts (HDFs) reach the
limit of their finite lifespan in culture (Serrano et al., 1997); (ii)
the senescence-like growth arrest provoked by oncogenic
signaling through the RAS-RAF-MEK pathway is also
accompanied by upregulation of p16 (Lin et al., 1998); (iii) a
number of studies have documented the downregulation of p16
concomitant with the outgrowth of fibroblasts with an extended
or indefinite lifespan (Drayton and Peters, 2002).
We have previously shown that human embryo lung
fibroblasts infected with HCMVundergo replicative senescence
Fig. 1. Effects of HCMV infection on p16 expression. (A) HCMV infection
upregulates p16 expression. HDFs were growth arrested in low-serum medium
for 72 h and then mock infected or infected with HCMVAD169 (MOI of 3).
Total cell extracts were prepared at the indicated times p.i., fractionated by
12.5% SDS-PAGE (25 μg protein/lane), and probed with anti-p16 mAb.
Immune complexes were detected with sheep anti-mouse immunoglobulins
conjugated to horseradish peroxidase and visualized by enhanced chemilumi-
nescence. Actin immunodetection was performed as an internal control. (B)
HCMV infection increases p16 mRNA content. HDFs were growth arrested in
low-serum medium for 72 h and then mock infected or infected with HCMV
AD169 (MOI of 3). Total RNAwas isolated at the indicated times after infection
and reverse transcribed. Real-time quantitative RT-PCR was then performed
with appropriate p16 TaqMan assays. The results were analyzed using a standard
curve model. For each time point, p16 RNA level was normalized according to
the expression of the actin gene. The data shown are the averages of two
independent experiments performed in triplicates ± the standard error of the
means (error bars). *P < 0.05, **P < 0.01 ***P < 0.001, one-way ANOVAwith
Bonferroni's multiple comparison test.
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galactosidase) activity, cessation of BrdU uptake, and increase
of PAI-1 (plasminogen activator inhibitor-1) mRNA expression
(Noris et al., 2002). Involvement of p16 in replicative
senescence, therefore, prompted us to investigate its role in
HCMV replication. Here, we report that HCMV infection of
HDF upregulates the expression of p16 gene required for
efficient viral replication.
Results
To investigate whether HCMV infection of quiescent cells
correlates with the regulation of cellular p16 expression, serum-
arrested HDF (Noris et al., 2002) was infected with HCMV
AD169 (MOI of 3), and at different time points post-infection
(p.i.), their p16 protein and mRNA contents were measured.
Quiescent cells (arrested in G0/G1 phase) were obtained by
culturing confluent HDF monolayers for 72 h in medium
containing 0.5% serum. Flow cytometry confirmed that more
than 90% were growth arrested. Immunoblotting analysis with
specific antibodies (Fig. 1A) showed that the level of p16
protein was low in mock-infected cells (lane 1) but began to
increase about 5-fold at 24 hpi (lane 2) and peaked to more than
11-fold at 72 hpi (lane 4). RNA samples were analyzed by
quantitative real-time RT-PCR. As shown in Fig. 1B, the p16
mRNA content of HCMV-infected HDF cells compared to
mock-infected cells started to increase at 12 hpi, peaked at
48 hpi (3.5-fold), and remained at relatively high levels (about
2.6-fold) up to 72 hpi. These results demonstrate that HCMV
infection of quiescent HDF leads to an increase in p16 mRNA
and protein levels.
To determine whether the increase in p16 mRNA correlated
with activation of the corresponding CDKN2A gene promoter,
we analyzed the effects of HCMV infection on the expression of
a transiently transfected luciferase reporter gene driven by the
CDKN2A promoter. HDF was transfected with the indicator
plasmid −869 spanning 869 nucleotides upstream from the p16
translation start site (Hara et al., 1996; Ohtani et al., 2001). After
18 h, cells were infected with HCMV (MOI 3) or mock infected,
and cell extracts were prepared and assayed for luciferase
activity 36 h later. As shown in Fig. 2A, HCMV infection
increased the luciferase activity by about 10-fold in transfected
cells, demonstrating that the virus regulates CDKN2A gene
expression primarily at the transcriptional level.
To map the nucleotide sequences involved in HCMV-
mediated regulation, mutants progressively deleted from −869
to −247 were employed (Hara et al., 1996; Ohtani et al., 2001).
The results (Fig. 2A) show that deletion of the sequences
between −869 and −604 had no effect on HCMV-mediated
transactivation, whereas truncation of the promoter from −604
to −247 markedly reduced HCMV transactivation (73%
reduction). However, responsiveness to HCMV was still
apparent in the shortest construct tested (−247). Altogether,
these results suggest that nucleotide sequences spanning the
entire −604 fragment play the major role in the responsiveness
of the whole CDKN2A promoter to HCMV infection. Since the
−247 DNA fragment includes potential binding sites for Ets-family transcription factors (Ohtani et al., 2001), and Ets factors
have been reported to be activated upon HCMV infection
(Castillo and Kowalik, 2002), we determined whether they were
involved in upregulation of the p16 promoter. HDF were
cotransfected with the −604 or −247 plasmids and a vector
expressing the DNA-binding domain of Ets2 (pIRES/E2DBD),
which acts as a dominant negative inhibitor for both Ets1 and
Ets2 (Ohtani et al., 2001). Transfected cells were infected with
HCMV, cell extracts prepared at 36 hpi, and assayed for
luciferase activity. Overexpression of E2DBD reduced by about
50% the activity observed with the −604 plasmid and almost
completely prevented reporter activation driven by the −247
plasmid (Fig. 2B), demonstrating that Ets1/2 transcription
factors contribute to the response of the p16 promoter upon
HCMV infection.
To further prove the involvement of Ets factors in the
HCMV-induced transactivation of the CDKN2A gene promot-
er, a plasmid containing the luciferase reporter gene driven by a
promoter mutated at both Ets sites (p16-247Mut2) (Mut2)
(Ohtani et al., 2001) was transfected into HDF. After 18 h, cells
Fig. 2. HCMV infection activates the p16 promoter. (A) Transactivation of the CDKN2A promoter. DNA (2 μg) from each of the progressively deleted p16 promoter
firefly luciferase constructs (Hara et al., 1996; Ohtani et al., 2001) was transiently cotransfected along with 70 ng of pRLSV40 (a renilla luciferase control reporter
vector) into HDF using the Lipofectamine Plus Reagent. After 18 h, cells were washed, mock infected (white bars) or infected with HCMVAD169 at MOI of 3 (black
bars). Total cytoplasmic extracts were isolated at 36 hpi and assayed for the two luciferase activity by the Dual-Luciferase Reporter Assay System. Firefly luciferase
reporter gene activities were normalized to the corresponding renilla luciferase expression. Promoter activity was calculated as the ratio of the activities of firefly and
renilla luciferase and expressed relative to that of the −869 construct considered as 100%, as previously described (Hara et al., 1996). The data shown are the averages
of three experiments ± the standard error of the means (error bars). (B) Ets1/2 transcription factors are involved in the HCMV-mediated p16 promoter transactivation.
HDF cells were transiently cotransfected with 2 μg of the −604 or −247 constructs, or the Mut2 (−247 construct mutated at both Ets sites), 70 ng of pRLSV40, and the
indicated amount of pIRES/E2DBD or pIRES/Empty vector using the Lipofectamine Plus Reagent. After 18 h, cells were washed and infected with HCMVAD169
(MOI of 3). Total cytoplasmic extracts were isolated at 36 hpi and assayed for the two luciferase activities by the Dual-Luciferase Reporter Assay System. Firefly
luciferase reporter gene activities were normalized to the corresponding renilla luciferase expression. Promoter activity was calculated as the ratio of the activities of
firefly and renilla luciferase, and expressed relative to that of the −604 construct considered as 100%. The data shown are the averages of three experiments ± the
standard error of the means (error bars).
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extracts were prepared and assayed for luciferase activity 36 h
later. As shown in Fig. 2B, the absence of functional Ets sites
strongly decreased the HCMV responsiveness of the −247
regulatory region of about 75%. Finally, the specificity of the
E2DBD activity was assessed by cotransfecting the Mut2 with
the E2DBD construct. As shown in Fig. 2B, the levels of
luciferase activity were comparable to those observed with the
Mut2 alone. Altogether, these results demonstrate that HCMV
infection of quiescent HDF cells enhances p16 gene expression
at transcriptional level, and that this activation is, at least in part,
mediated by Ets transcription factors.
The results achieved so far raised the question of whether
induction of p16 expression by HCMV is needed for viral DNAreplication in quiescent cells, or whether it stems from a more
generalized stimulation of host transcription and translation in
HCMV-infected cells. We therefore analyzed the extent to
which HCMV infection is influenced by functional p16 by
evaluating the ability of the virus to productively replicate in
fibroblasts homozygous for an intragenic deletion in CDKN2A
locus and devoid of functional p16 or in HDF expressing short
interference RNA (siRNA) to downregulate p16 expression.
Leiden cells are dermal fibroblasts derived from a rare
individual who is homozygous for a 19-bp deletion in exon 2
of the CDKN2A gene (Huot et al., 2002). They lack functional
p16 but retain p14ARF functions (Brookes et al., 2002). HDFs
(designated FOO3) derived from a first-degree relative, who is
heterozygous for the mutation and expresses functional p16,
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and Leiden cells were infected at two multiplicities of infection
(MOI of 0.1 and 1 respectively) and viral titers in the
supernatants of the cultures were determined at various times
p.i. As shown in Fig. 3, HCMV replication in Leiden cells at
either MOI was significantly reduced, since the viral yields were
about 2 orders of magnitude lower than those obtained with
FOO3 and HDF. These differences do not depend on delayed
kinetics, since the amount of virus these p16-deficient cells
produced was significantly lower than that measured in both
FOO3 and HDF, even at 9 days p.i., indicating that impairment
of p16 expression affects HCMV replication in fibroblasts.
To determine what step of HCMV replication was dependent
on functional p16, viral DNA synthesis and protein expression
in HCMV-infected Leiden cells were examined. Quiescent
HDF, FOO3 and Leiden cells were infected at twoMOI (0.1 and
1 respectively), and viral DNA levels were measured at various
times p.i. by quantitative real-time PCR. As shown in Fig. 4A,
at early time points p.i. (1 day p.i.), the amount of viral DNA
was similar among Leiden cells, FOO3 cells, and HDF,
demonstrating that there is a comparable infection efficiency
in the three cell lines. Therefore, the inability of Leiden cells to
express a functional p16 greatly reduces HCMV replication at
steps downstream the early phases of infection, i.e., virusFig. 3. Lack of functional p16 impairs HCMV replication. Normal HDF, FOO3
and Leiden cells, growth arrested in low-serum medium for 72 h, were infected
with HCMV AD169 (MOI of 0.1 or 1), and the supernatants collected at
different days p.i. (d.p.i.). HCMV titers (pfu/ml) were determined by standard
plaque assay on HDF cells. The data shown are the means of three independent
determinations.
Fig. 4. Viral DNA and protein synthesis are reduced in Leiden cells. (A)
Replication of HCMV DNA is reduced in Leiden cells. Normal HDF, FOO3,
and Leiden cells were growth arrested in low-serum medium for 72 h and then
infected with HCMVAD169 (MOI of 0.1 or 1). At different days p.i. (d.p.i.),
total genomic DNA was purified and subjected to real-time quantitative PCR.
The results were analyzed using a standard curve model. Normalized viral loads
are expressed as HCMV copies/ng human genomic DNA. The data shown are
the averages of three replicates ± the standard error of the means (error bars). (B)
Expression of HCMV proteins in Leiden and FOO3 cells. FOO3 and Leiden
cells were growth arrested in low-serum medium for 72 h and then mock-
infected or infected with HCMVAD169 (MOI of 3). Samples (25 μg) of cell
lysates were fractionated by 8.5% SDS-PAGE and analyzed by immunoblotting
with anti-IEA, anti-UL44 or anti-UL99 mAbs. Actin immunodetection was
performed as an internal control.
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inhibition included other events in the HCMV growth cycle, the
expression of immediate-early (IE1 and IE2), early (UL44), and
late (UL99) protein was examined by immunoblotting analysis.
As shown in Fig. 4B, the expression of the IE1 and IE2 was
significantly reduced in Leiden cells throughout infection. The
expression of both an early gene, UL44 (DNA polymerase
processivity factor), and a true late gene (UL99) was reduced as
well. These results demonstrate that HCMV gene expression is
significantly reduced by the impairment of functional p16 even
at the IE phase, and that all subsequent events in the cascade,
including the synthesis of viral DNA, are downregulated.
To further confirm the dependence of virus growth on
functional p16 observed in Leiden cells, we next investigated
the effects of depletion of p16 in normal HDF by using a siRNA
approach. To this purpose, HDFs were infected with recombi-
nant retroviruses encoding the p16-specific siRNA (p16-
siRNA/AB) or the ineffective p16-siRNA/GH produced as
described by Shin et al. (2004). The levels of p16 protein were
then assessed by immunoblotting after 14-day puromycin
selection to enrich for cells lacking p16 expression. Consistent
with the results reported by Shin et al. (2004), infection with
p16-siRNA/AB retrovirus significantly suppressed p16 proteinFig. 5. Retroviral-mediated p16 siRNA downregulates HCMV replication. HDF
cells were infected with high-titre retrovirus expressing the effective p16-
siRNA/AB or the ineffective p16-siRNA/GH (Shin et al., 2004) and selected
with 1 μg/ml puromycin (Sigma-Aldrich). After 2 weeks, HDFs were expanded,
infected with HCMVAD169 (MOI of 0.1 or 1), and the supernatants collected at
different d.p.i. HCMV titers (pfu/ml) were determined by standard plaque assay
on HDF cells. The data shown are the means of two independent determinations.levels without affecting β-actin levels, whereas the ineffective
p16-siRNA/GH retrovirus had no effects on both p16 and β-
actin levels (data not shown). To analyze the effects of p16
knock-down on HCMV replication, HDFs were first infected
with p16-siRNA/AB or p16-siRNA/GH, enriched by puromy-
cin selection, and then infected with HCMV at increasing MOI
(0.1 or 1). As shown in Fig. 5, HCMV replication in HDF
expressing p16-siRNA/AB was significantly reduced at both
MOI, since the viral yields were about 2.0 orders of magnitude
lower than those obtained with HDF infected with the
ineffective p16-siRNA/GH retrovirus or with normal HDF.
Thus, these results confirm that functional p16 is required for
optimal HCMV replication.
Discussion
To create an environment suited for its replication, HCMV
must activate the appropriate cellular biosynthetic pathways for
DNA synthesis since it lacks functional virus-encoded dNTPs-
synthesizing enzymes such as thymidine kinase (TK), dihy-
drofolate reductase (DHFR), thymidylate synthase (TS), and
ribonucleotide reductase (RR). Thus, to gain selective access to
the newly synthesized dNTPs, the virus prevents replication of
the host cell DNA by blocking cell cycle progression (Mocarski
and Courcelle, 2001; Pass, 2001; Kalejta and Shenk, 2002;
Landolfo et al., 2003). Determining how the virus stimulates
G0-arrested cells to entry an aborted cell cycle is important for
understanding the biology of the virus–cell interaction.
Here, we present data demonstrating that HCMV-mediated
upregulation of endogenous p16 is actively promoted by the
virus, as shown by the experiments with the reporter luciferase
gene driven by the CDKN2A promoter. Moreover, by using
CDKN2A promoter deletion mutants and an expression vector
encoding a dominant negative inhibitor for both Ets1 and Ets2,
we demonstrate that the HCMV-induced transactivation of the
CDKN2A promoter is mediated through its conserved Ets-
binding site.
Stimulation of p16 induction is of physiological significance
during HCMV infection as shown by the following observa-
tions: (i) it is triggered by IE gene expression (Noris et al.,
2002); (ii) in Leiden cells lacking functional p16, viral gene
expression and DNA synthesis are significantly reduced
compared to heterogenous FOO3 cells; (iii) in Leiden, but not
in FOO3 cells, and in HDF infected with a p16-siRNA
retrovirus HCMV replication is reduced. Altogether, these
results demonstrate that HCMV depends on functional p16 for
its optimal replication.
A senescence phenotype can be induced when primary cells
are challenged by an activated Ras oncogene or its downstream
effectors Raf and MEK (Serrano et al., 1997). Growth arrest is
accompanied by elevated p16 levels, and its ectopic expression
in HDFs causes the senescent phenotype (Campisi, 2001). The
mechanisms by which oncogenic ras induces senescence
depend on cellular context and signal intensity (Deng et al.,
2004). It has indeed been demonstrated that the p16/Rb pathway
plays a critical role in Ras-induced senescence in human
fibroblasts (Drayton et al., 2003). Consistent with these
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with oncogenic human Ha-ras results in cells which are
permissive for HCMV infection and IE gene expression
(Shelbourn et al., 1989). Furthermore, previous studies from
our laboratory showed that products of Ras oncogenes strongly
stimulate the activity of a reporter gene driven by a 1.2-kb
fragment spanning the MCMV IE gene enhancer, and that this
transactivation could be prevented by cotransfection of a
dominant inhibitor mutant Ha-ras (Gaboli et al., 1995). The
findings that HCMV triggers p16 in the early phases of
infection and does not replicate in cells lacking a functional p16,
therefore, demonstrate that the virus may exploit the ras-p16-
pRb axis to stimulate the senescence program favorable for its
replication.
Material and methods
Cells
Primary low passage HDFs (human diploid fibroblasts) or h-
TERT immortalized Leiden HDFs and FOO3 HDFs (Brookes et
al., 2002) and 293T cells were grown in Dulbecco's modified
Eagle medium (DMEM) containing 10% fetal calf serum (FCS)
at 37 °C in a 5% CO2 atmosphere. Quiescent cells (arrested in
G0/G1 phase) were obtained by incubating confluent mono-
layers for 72 h in medium containing 0.5% serum (low-serum
medium). Flow cytometry demonstrated that more than 90%
were growth arrested.
Virus stock preparation and virus infection
The HCMV AD169 strain, purchased from the American
Type Culture Collection (ATCC VR-538), was prepared by
infecting semiconfluent layers of HDF at a multiplicity of
infection (MOI) of about 0.001 plaque forming units (pfu) per
cell. Virus stocks were collected when cell lysis was almost
complete. Cells were scraped, briefly sonicated, filtered through
0.45-μm-pore-size filters, and stored at −80 °C. Virus titers
were measured by a standard plaque assay for HCMVon HDF
cells.
HCMV stock solutions containing approximately 5 × 106 to
8 × 106 pfu/ml were used. Mock-infecting medium was
prepared from uninfected cells according to the same procedure
used for the preparation of HCMV. For HDF infections, cells
were synchronized in G0 by culturing confluent monolayers for
72 h in medium containing 0.5% serum (low-serum medium)
and infected at a MOI varying from 0.1 to 3 as previously
reported (Noris et al., 2002). Virus adsorption was performed
for 2 h at 37 °C (time zero). At the end of the adsorption, the
low-serum medium removed from the cells before infection was
returned to the plates to avoid any cellular stimulation that could
have resulted from the addition of fresh serum growth factors.
Mock-infected control cultures were exposed to an equal
volume of mock-infecting medium.
The HCMV yield was determined in cells grown to
subconfluence in 12-well plates, incubated in low-serum
medium for 72 h, and thereafter infected with HCMV (MOIof 0.1 or 1). Supernatants were then collected at different time
points post-infection and assayed for infectivity by a standard
plaque assay for HCMVon HDF cells.
Transfection assay
The p16 promoter-reporter plasmids, the pIRES2-EGFP/
E2DBD (pIRES/E2DBD), the pIRES2-EGFP/Empty (pIRES/
Empty) were described previously (Ohtani et al., 2001).
Plasmids were transiently transfected in HDF cells using
Lipofectamine Plus Reagent (InVitrogen). The plasmid RL-
SV40 (Promega), which provides constitutive expression of
renilla luciferase, was included as a control for transfection
efficiency. Eighteen hours after transfection, cells were mock
infected or infected with HCMV (MOI 3), and the luciferase
activity was then measured at 36 hpi. Briefly, the cells were
washed twice with phosphate-buffered saline (PBS), scraped
from the plates in PBS containing 1 mM EDTA, and collected
by centrifugation. The pellets were resuspended in 100 μl of
passive lysis buffer (Promega), and soluble proteins were
recovered after centrifugation. Supernatants were quantified for
protein concentration, and aliquots were assayed for activity of
both firefly and renilla luciferases in a single tube luminometer
Lumino (Stratec, Biomedical Systems). The promoter activity
was calculated as the ratio of the activities of firefly and renilla
luciferase and expressed relative to that of the −869 construct as
previously described (Hara et al., 1996). In the experiments
using pIRES/E2DBD or pIRES/Empty vectors, promoter
activity was expressed relative to that of −604 construct.
Real-time PCR
For p16 transcript quantification, total RNA was extracted
with Nucleo Spin RNA II (Macherey-Nagel, Düren, Germany).
One microgram of total RNA was reverse transcribed, after
5 min of denaturation at 70 °C, in 20 μl reaction mixture
containing 1 mM of dNTP mix, 200 ng of random hexamer
primers, 20U Ribolock Ribonuclease inhibitor and 200 U
RevertAid h Minus M-MuLV Reverse Transcriptase (all from
Fermentas Life Sciences). The reaction mixture was incubated
at 25 °C for 10 min and 42 °C for 60 min. Real-time quantitative
RT-PCR was performed on GeneAmp 7000 Sequence Detection
System (Applied Biosystems, Foster City, CA, USA). The
analysis of p16 gene expression was performed using
commercial gene expression assay from Applied Biosystems
(Assay-on-Demand: p16, assay no. Hs00233365_m1). The
housekeeping gene beta-actin (Assay-on-Demand: ACTB,
assay no. HS99999903_m1) was used to normalize for
variations in cDNA. PCR on each sample was performed in
triplicate, in a 25 μl volume containing 1 μl of cDNA, 12.5 μl of
2× TaqMan Universal PCR Master Mix (Applied Biosystems)
and 1.25 μl of 20× Assay-on-Demand Mix. The thermocycler
parameters were 95 °C for 10 min, followed by 40 cycles of 95
°C for 15 s, and 60 °C for 1 min. The results were analyzed
using a standard curve model.
To determine HCMV DNA copy number cells were grown
to subconfluence in 12-well plates, incubated in low-serum
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At the indicated times p.i., cells were then harvested, and total
DNA was isolated by resuspending cell pellets in lysis buffer
(10 mM Tris–HCl [pH 8.0], 25 mM EDTA, 100 mM NaCl,
0.5% SDS, 100 μg of proteinase K/ml) and incubating the
mixture at 50 °C for 18 h. The digestion was then followed by
phenol–chloroform extraction, ethanol precipitation, and
RNase treatment (1 μg of RNase A per milliliter for 1 h at
37 °C). Viral DNA levels were measured by quantitative real-
time PCR using previously described probe and primers
amplifying the IE2 gene (Tanaka et al., 2000). HCMV DNA
copy numbers were normalized by division by the amount of
human 18S rRNA gene (Assay-on-Demand: 18S, assay no.
HS99999901_s1, Applied Biosystems) with the quotient
representing the actual amount of amplifiable genomic DNA
per reaction. Standard curves were constructed using values
from serially diluted genomic DNA mixed with an IE2
encoding plasmid (pSGIE72, Gribaudo et al., 2002). PCR on
each sample was performed in triplicate with the following
thermocycler parameters: 95 °C for 10 min, 40 cycles of 95 °C
for 15 s and 61 °C for 1 min.
Retroviral-mediated p16 short interfering RNA
The recombinant retroviral pBabe/p16-siRNA/AB, carrying
the p16 exon 1αAB effective sequence, was kindly provided by
JamesW. Rocco, Massachusetts General Hospital, Boston (Shin
et al., 2004). The recombinant retroviral pBabe/p16-siRNA/
GH, carrying an ineffective sequence, was generated by cloning
the p16-siRNA/GH cassette from the pBSU6/p16-siRNA/GH
plasmid (Shin et al., 2004) into the NheI site of the pBabe
vector. As previously reported, the AB sequence was the most
effective in decreasing p16 expression, whereas the GH
sequence was ineffective and therefore used as negative control.
High-titer retroviral supernatants were generated by transient
transfection of 293T cells and used to infect HDF cells as
previously described (Shin et al., 2004). After 6-h culture, the
medium was replaced by fresh medium and incubation
continued for 24 h. Retrovirus infected HDF cells expressing
p16 siRNA/AB or p16 siRNA/GH were then selected with 1 μg/
ml puromycin (Sigma-Aldrich) for 2 weeks, expanded, and
used for experiments.
Immunoblotting analysis
At the indicated times, cells were washed with PBS,
scraped from the plates in PBS containing 2 mM EDTA, and
collected by centrifugation. The cell pellets were resuspended
in SDS lysis buffer (125 mM Tris–HCl [pH 6.8], 10 mM
dithiothreitol, 3% SDS) containing 1 mM phenylmethylsulfo-
nyl fluoride plus pepstatin (1 μg/ml) and aprotinin and
leupeptin (both 4 μg/ml). Lysed cells were briefly sonicated,
boiled, and cleared by centrifugation (15,000 × g). Protein
concentrations were measured with the protein determination
kit Dc (Bio-Rad Laboratories). Total cells lysates were
fractionated by electrophoresis in 8.5 or 12.5% SDS-
polyacrylamide gels according to standard protocols. Proteinswere transferred to Immobilion-P membranes (Millipore) with
a semidry apparatus (Schleicher and Schuell), and membranes
were blocked in 5% nonfat dry milk in 10 mM Tris–Cl (pH
7.5) −100 mM NaCl–0.1% Tween 20. Immunoblot analysis
was then performed with Abs against p16 (Santa Cruz
Biotechnology, Inc.), β-actin (Chemicon International), IEA
(anti-IE1/IE2, Argene Biosoft), UL44 and UL99 (Goodwin
Institute). Appropriate secondary Abs conjugated with horse-
radish peroxidase were used (Amersham), and the immune
complexes were visualized by enhanced chemiluminescence
(Pierce supersignal). Densitometry was performed by scanning
the radiographs and then analyzing the bands with TotalLab
software (Amersham).
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